History and Evolution of Pain Management and Opioid Use In America

History and Evolution of Pain Management and Opioid Use In America 

Not accounting for acute pain, 26 percent of Americans aged 20 and older report experiencing pain of any sort that lasted for longer than 24 hours. Furthermore, 23.4 million adults reported experiencing "a lot of pain" in the past 3 months on a 2012 National Health survey. Chronic pain can lead to a number of negative consequences for individuals, such as depression, anxiety, disrupted sleep, work and social disability, a reduced quality of life, and even suicidal ideation. Throughout the past 30 years, pain management in America has evolved from not being a priority to having pain being considered as a fifth “vital sign.” In this webinar, you will learn of some tools to help you measure a client’s pain, pain management requirements as dictated by the Joint Commission, and the prevalence of opioids in treating chronic pain. You will then explore opioids in greater detail, learning about the prescribing epidemic, potentially adverse consequences, misuse, and addiction. Lastly, you will hear about responses from the government and healthcare professionals to this epidemic, as well as some alternatives to opioids in relieving pain. This course is appropriate for all licensed professionals who work with opioid addiction and professionals who are potentially responsible for prescribing and monitoring the use of opioids.


Hours: 1.25


Certificates provided by accrediting body (2 Match)

California Association of Alcohol and Drug Educators

1.25 HOURS

Relias Learning is an approved provider of Continuing Education. Provider number: CP40 910 H 0318 for 1.25 CEHs.

Oklahoma Board of Licensed Alcohol and Drug Counselors

1.25 HOURS

Course Details

Course Code: REL-HHS-0-W002
Hours: 1.25
Type: Online Course
Content Expiration Date: 2/28/2021
Learning Objectives:
Discuss what pain is, its definitions, types, and major categories
Describe the consequences of chronic pain, as well as its physical and economic burden
Summarize the evolution of pain management and how opioid prescribing has become an epidemic
Identify how healthcare professionals should respond to the adverse consequences of prescription opioids
Instructor: Jack M. Gorman, M.D.
Jack M. Gorman, M.D. founded Franklin Behavioral Healthcare Consultants in 2010. He is currently CEO and Chief Scientific Officer. Franklin Behavioral Healthcare Consultants provides expert guidance to biotech companies and to health care organizations in order to improve CNS drug development and the efficacy and cost-effectiveness of mental health care. Before founding Franklin Behavioral Healthcare Consultants, Dr. Gorman was Chief Scientific Officer and Senior Vice-President of both Comprehensive NeuroScience Inc and Care Management Technologies Inc. In those positions he used his two decades of experience in neuroscience, psychiatry, and psychopharmacology to help develop new programs in behavioral health care management and CNS drug development. Dr. Gorman was a summa cum laude graduate of the University of Pennsylvania, received his medical degree from the College of Physicians and Surgeons of Columbia University and completed residency and fellowship training in the Department of Psychiatry of Columbia University/New York State Psychiatric Institute program. He was on the faculty of Columbia University from 1981 to 2002, becoming Lieber Professor, Vice-chair for Research and Director of the Lieber Center for Schizophrenia Research. He then became Klingenstein Professor and Chair of the Department of Psychiatry of the Mount Sinai School of Medicine. Dr. Gorman was elected a fellow of the American College of Neuropsychopharmacology, has authored or co-authored more than 400 scientific articles and chapters, and was continuously funded by the National Institutes of Health for his research from 1981 until 2006 and received three research grants from the Brain and Behavior Institute (formerly NARSAD). He won numerous awards for his research and service to psychiatry from organizations like the American Psychiatric Association, American College of Neuropsychopharmacology, Mental Illness Foundation, and Society for Cognitive Behavioral Therapy and is one of the most frequently cited authors in the psychiatry and neuroscience literatures. Dr. Gorman is co-editor of the textbooks Treatments that Work, now in its third edition, and Comprehensive Textbook of AIDS Psychiatry and author of the popular book The Essential Guide to Psychiatric Drugs, which appeared in its fourth edition in 2007. His expertise is in behavioral healthcare management and improvement, psychopharmacology, and clinical and basic neuroscience. Dr. Gorman has been married for 36 years to New York City psychiatrist Dr. Lauren Kantor Gorman and is the father of two daughters, Dr. Rachel Gorman and Dr. Sara Gorman. He currently devotes substantial time to work with philanthropic organizations including the Mental Health and Wellness Task Force of the UJA-Federation of New York; the JED Foundation; and the American Jewish World Service. Disclosure: Jack M. Gorman, M.D. has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: Entry, Intermediate level Alcohol and Drug Counselors; Entry, Intermediate level Physicians; Entry, Intermediate level Psychologists; Nurses; in the following settings: Health and Human Services.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.